Cases 41 - 50 of 360
SHANNON v. MYLAN LABORATORIES, LTD. et al
as 1:2022cv03870
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
VINCENT SHANNON
Defendant:
MYLAN LABORATORIES, LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HOLMSTROM v. ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD. et al
as 1:2022cv02882
Plaintiff:
JAMIE HOLMSTROM and THE ESTATE OF ANNETTE GOEBEL
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THE ESTATE OF ROBERT COOPER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01635
Plaintiff:
KIM COOPER and THE ESTATE OF ROBERT COOPER
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SMITH v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01245
Plaintiff:
JIM SMITH
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ESTATE OF SEBASTIEN THOMAS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01247
Plaintiff:
JUDITH THOMAS and ESTATE OF SEBASTIEN THOMAS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
POMA v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01118
Defendant:
FRANCESCO POMA, ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DARABARIS v. MYLAN LABORATORIES LTD. et al
as 1:2022cv01048
Plaintiff:
JEREMY DARABARIS
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GALLAGHER v. HETERO DRUGS, LTD. et al
as 1:2022cv00930
Plaintiff:
KELLY GALLAGHER
Defendant:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, HETERO DRUGS, LTD., HETERO LABS, LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BRANCH v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00582
Plaintiff:
TERRELL BRANCH
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ANDERSON v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv00449
Plaintiff:
VINCENT ANDERSON
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
